Nov 9 (Reuters)-
SymBio Pharmaceuticals Limited
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2018 Sep 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.03 2.42 4.20
(+25.5 pct) (+71.7 pct) (+22.0 pct)
Operating loss 1.91 loss 3.51 loss 2.98
Recurring loss 1.94 loss 3.55 loss 3.04
Net loss 1.94 loss 3.55 loss 3.06
EPS loss 31.31 yen loss 72.64 yen loss 46.53 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - SymBio Pharmaceuticals Limited.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T